• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受腹膜透析的老年患者总体生存率提高。

Improved overall survival of elderly patients on peritoneal dialysis.

作者信息

Joglar F, Saadé M

机构信息

Auxilio Mutuo Hospital, University of Puerto Rico, San Juan.

出版信息

Adv Perit Dial. 1991;7:63-7.

PMID:1680459
Abstract

Clinical complications and outcome of 50 patients, age 65 or older, on dialysis during 1985-1990 were studied. There were three groups: Peritoneal Dialysis (PD-10 pts.), Hemodialysis (HD-28 pts.), and both for at least one month each (PD-HD 12 pts.) (8 HD to PD and 4 PD to HD). Analysis included sex, age, bacteremia associated to acute vascular accesses (AVA), peritonitis (PD), other illnesses, hospital days, blood chemistries, quality of life (active, sedentary or bedridden). The most frequent causes of death were septicemia and cardiac failure. No difference was found in age, chemistries, hemoglobin, illnesses or quality of life. The results showed a significant improved overall survival for those in the PD group (77.8%, p less than 0.05) as compared to HD or PD-HD group. Therefore, more emphasis should be placed on using PD for elderly patients.

摘要

对1985年至1990年间50名65岁及以上接受透析治疗的患者的临床并发症及预后进行了研究。分为三组:腹膜透析组(PD,10例)、血液透析组(HD,28例)以及每组至少接受过一个月两种透析方式的组(PD-HD,12例)(8例从HD转为PD,4例从PD转为HD)。分析内容包括性别、年龄、与急性血管通路相关的菌血症(AVA)、腹膜炎(PD)、其他疾病、住院天数、血液化学指标、生活质量(活动、久坐或卧床)。最常见的死亡原因是败血症和心力衰竭。在年龄、化学指标、血红蛋白、疾病或生活质量方面未发现差异。结果显示,与HD组或PD-HD组相比,PD组患者的总体生存率显著提高(77.8%,p<0.05)。因此,对于老年患者应更加强调使用腹膜透析。

相似文献

1
Improved overall survival of elderly patients on peritoneal dialysis.接受腹膜透析的老年患者总体生存率提高。
Adv Perit Dial. 1991;7:63-7.
2
Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients.新发性血液透析患者与腹膜透析患者感染并发症的比较。
Clin J Am Soc Nephrol. 2006 Nov;1(6):1226-33. doi: 10.2215/CJN.01230406. Epub 2006 Oct 11.
3
Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.急性非计划性腹膜透析与血液透析的可比结局。
Nephrol Dial Transplant. 2012 Jan;27(1):375-80. doi: 10.1093/ndt/gfr262. Epub 2011 May 28.
4
Hospitalizations in patients treated sequentially by chronic hemodialysis and continuous peritoneal dialysis.接受慢性血液透析和持续性腹膜透析序贯治疗的患者的住院情况。
Adv Perit Dial. 2009;25:72-5.
5
[Development of peritoneal dialysis at Rijeka Clinical Hospital Center].[里耶卡临床医院中心腹膜透析的发展]
Acta Med Croatica. 2004;58(3):215-20.
6
Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.从血液透析转为腹膜透析患者的治疗结果
Nephrol Dial Transplant. 2009 Sep;24(9):2889-94. doi: 10.1093/ndt/gfp132. Epub 2009 Apr 2.
7
Comparison of outcome and quality of life: haemodialysis versus peritoneal dialysis patients.结局与生活质量比较:血液透析与腹膜透析患者
Singapore Med J. 2009 Feb;50(2):185-92.
8
CAPD versus hemodialysis (HD): 7 years of experience.持续性非卧床腹膜透析与血液透析(HD):7年经验
Adv Perit Dial. 1989;5:52-5.
9
High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.腹膜透析时的高膜转运状态与转为血液透析后的生存降低无关。
Nephrol Dial Transplant. 2007 Oct;22(10):3005-12. doi: 10.1093/ndt/gfm324. Epub 2007 Jun 2.
10
An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.使用尼日利亚产腹膜透析液对腹膜透析和血液透析的有效性及益处进行的分析。
Afr J Med Med Sci. 2005 Sep;34(3):227-33.

引用本文的文献

1
Prognosis of bedridden patients with end-stage renal failure after starting hemodialysis.终末期肾衰竭卧床患者开始血液透析后的预后
Clin Exp Nephrol. 2007 Jun;11(2):147-150. doi: 10.1007/s10157-007-0468-5. Epub 2007 Jun 28.
2
Renal replacement treatment. Elderly people must not be denied CAPD.肾脏替代治疗。绝不能拒绝老年人进行持续性非卧床腹膜透析(CAPD)。
BMJ. 1993 Aug 7;307(6900):381. doi: 10.1136/bmj.307.6900.381-a.